This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $785,951 to New York University (NYU) School of Medicine to conduct research on improving provider adoption of clinical decision support tools for pulmonary embolism risk assessment.
The project aims to evaluate the impact of incorporating behavioral economic "nudge" strategies into a clinical decision support tool for managing pulmonary embolism diagnostic imaging. This EHR-agnostic tool leverages a validated clinical prediction rule to support evidence-based CT ordering practices and reduce unnecessary testing. The research will be conducted across 3 health systems and 10 emergency departments using a stepped-wedge, cluster randomized trial design. Key objectives include examining the nudge implementation strategy's impact on provider adoption of guideline-concordant CT ordering, determining its effect on behavioral barriers to adoption, and confirming the clinical effectiveness across diverse patient populations. NYU is collaborating with Baylor College of Medicine and North Shore University Hospital as sub-awardees on various aspects of the research study.
Generated 12/10/24, 8:05 AM